Clinical Drug Trial Centre

CUHK-HKEH Clinical Drug Trial Centre (CDTC)

The CUHK-HKEH Clinical Drug Trial Centre was established to conduct clinical studies in compliance with the guidelines of Good Clinical Practice (GCP) to protect subjects’ right and safety, as well as to ensure the integrity of study data which are credible and accurate. Our Centre is located in Hong Kong Eye Hospital. Since 2006, both Hong Kong Eye Hospital (HKEH) and Joint Shantou International Eye Centre (JSIEC) have been accredited by the China Food and Drug Administration (CFDA) as trial centres in ophthalmology.

Industrial Collaborative Studies

The centre has conducted a number of sponsored clinical trials in different subspecialty; including clinical trials for the purpose of US Food and Drug Administration (FDA) certification. Listed are the sponsored clinical trials which are ongoing in our centre:

Phase 3
  • Artemis (Allergan): open-angle Glaucoma or ocular Hypertension
  • Brilliance (Novartis): choroidal neovascularization secondary to pathologic myopia
  • Blossom (Novartis): macular edema secondary to branch retinal vein occlusion
  • Camellia (Novartis): macular edema secondary to central retinal vein occlusion
  • Cedar(Allergan): neovascular age-related macular degeneration
  • Planet (Bayer): polypoidal choroidal vasculopathy
Phase 4
  • EVEREST II (Novartis): symptomatic macular polypoidal choroidal vasculopathy
  • 24-hour Intraocular Pressure Profile (Santen): primary open angle glaucoma, primary angle closure glaucoma or ocular hypertension
Medical Devices
  • Ologen™ Corneal Shield (Aeon Astron): Evaluate the safety of collagen corneal shield